What Does Sofinnova Partners Do?

Total employees115
HeadquartersParis
Founded1972

Sofinnova Partners is a leading European venture capital firm dedicated to life sciences, with a specific focus on healthcare and sustainability. Established in 1972, the firm has a long history of backing innovative entrepreneurs and groundbreaking companies from seed to later-stage. Sofinnova Partners invests in biotechnology, medical devices, and industrial biotechnology sectors, aiming to transform groundbreaking science into tangible solutions for patients and the planet. They operate with a multi-fund strategy covering the entire value chain of life sciences investments.

Where Is Sofinnova Partners's Headquarters?

Sofinnova Partners officeSofinnova Partners officeSofinnova Partners officeSofinnova Partners office
*Images sourced via web search. Rights belong to original owners

HQ Function

Central hub for European investment strategy, fund management, portfolio company support, and global operational oversight.

Notable Features:

Located in the prestigious 9th arrondissement, near Opéra Garnier, reflecting the firm's established presence in a key European financial center. Modern office facilities designed to foster collaboration and innovation.

Work Culture:

Characterized by a deep scientific and financial expertise, a collaborative approach with entrepreneurs, and a long-term vision for value creation in life sciences. The culture encourages rigorous analysis, open debate, and a commitment to ethical investment.

HQ Significance:

The Paris headquarters is historically significant as the firm's founding location and remains central to its European focus, providing proximity to a rich ecosystem of research institutions, biotech companies, and talent.

Values Reflected in HQ: The headquarters' location and setup reflect Sofinnova's commitment to excellence, innovation, its strong European identity, and fostering global connections in the life sciences sector.

Location:

While deeply rooted in Europe with offices in Paris, London, and Milan, Sofinnova Partners maintains a global outlook. The firm invests primarily across Europe but also selectively in North America and other key international innovation hubs. Their global network supports portfolio companies with international expansion, access to diverse talent pools, cross-border M&A opportunities, and strategic partnerships worldwide.

Street Address:

7-11 Boulevard Haussmann

City:

Paris

State/Province:

Île-de-France

Country:

France

Where Else Does Sofinnova Partners Operate Around the World?

London, United Kingdom

Address: 25 Maddox Street, London W1S 2QN, United Kingdom

Enhances access to UK biotech and medtech innovations, fosters relationships with UK research institutions and entrepreneurs, and supports portfolio companies' European and global expansion.

Milan, Italy

Address: Via San Prospero 4, 20121 Milan, Italy

Focuses on tapping into Italy's growing innovation landscape in life sciences, supporting local entrepreneurs, and bridging Italian scientific excellence with global venture capital.

Buying Intent Signals for Sofinnova Partners

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Sofinnova Partners? Meet the Executive Team

As of April 2025, Sofinnova Partners' leadership includes:

Antoine Papiernik - Chairman and Managing Partner
Henrijette Richter - Managing Partner
Graziano Seghezzi - Managing Partner
Maina Bhaman - Managing Partner
Tom Burt - Managing Partner, Capital Strategies

Who's Investing in Sofinnova Partners?

Sofinnova Partners has been backed by several prominent investors over the years, including:

As a venture capital firm, Sofinnova Partners raises funds from Limited Partners (LPs). These typically include institutional investors such as pension funds, insurance companies, sovereign wealth funds, endowments, foundations, and family offices from Europe, Asia, and North America. Specific names of LPs are generally not publicly disclosed to maintain confidentiality.

What Leadership Changes Has Sofinnova Partners Seen Recently?

Hire2
Exits0

Sofinnova Partners has actively strengthened its team over the past year with key promotions to Partner and strategic hires at the Venture Partner level, enhancing its expertise across various investment strategies including Capital, MD Start, Industrial Biotechnology and Crossover strategies.

New Appointments:

Andrew C. von Eschenbach, M.D., Dr. Andrew C. von Eschenbach appointed as Venture Partner to provide strategic guidance and leverage his extensive network for the Industrial Biotechnology fund.
Dr. Joe Wiley, Dr. Joe Wiley joined as Venture Partner to enhance the Crossover Strategy team's ability to identify and support promising later-stage companies.

What Technology (Tech Stack) Is Used bySofinnova Partners?

Discover the tools Sofinnova Partners uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Sofinnova Partners Email Formats and Examples

Sofinnova Partners primarily uses the email format consisting of the employee's first initial followed directly by their last name, all at the sofinnovapartners.com domain. This is a common pattern for professional communication within the firm.

flastname@sofinnovapartners.com (e.g., jdoe@sofinnovapartners.com)

Format

apapiernik@sofinnovapartners.com

Example

90%

Success rate

What's the Latest News About Sofinnova Partners?

Business Wire / Sofinnova PartnersApril 25, 2024

Sofinnova Partners Announces First Close of Sofinnova Digital Medicine I at €190 Million

Sofinnova Partners, a leading European life sciences venture capital firm, announced the first closing of its pioneering digital medicine fund, Sofinnova Digital Medicine I, securing €190 million. This fund is dedicated to investing in early-stage companies at the intersection of biology, data, and computation, aiming to foster the next wave of healthcare innovation....more

Sofinnova PartnersJanuary 18, 2024

Sofinnova Partners Strengthens Its Team with Two Partner Promotions

Sofinnova Partners announced the promotion of Kinam Hong (Capital Strategy) and Guillaume Bray_Ménage (MD Start Strategy) to Partner. These promotions underscore the firm's commitment to nurturing internal talent and reinforcing its specialized investment teams....more

Fierce Biotech / Sofinnova PartnersJuly 12, 2023

Sofinnova Partners Co-Leads $60M Series B for Ablaze Pharmaceuticals

Sofinnova Partners co-led a $60 million Series B financing round for Ablaze Pharmaceuticals, a clinical-stage company focused on developing targeted radiopharmaceutical therapies for cancer treatment. This investment highlights Sofinnova's commitment to advancing innovative oncology solutions with global potential....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Sofinnova Partners, are just a search away.